HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Pre-exposure Option for Reducing HIV in the UK.(PROUD) [Phase 4]
Phase 4 PROUD trial update reporting completion of a pre-exposure prophylaxis study in the UK to reduce HIV infection.
-
CLINICAL_TRIALS research · 2017-01-04Clinical Trial Update: Effects of Aerobic Exercise on CD4 Count,Viral Load,Selected Psycho-social Trait [EARLY_Phase 1]
A Phase 1 trial evaluating the effects of aerobic exercise on CD4 count, viral load, and selected psychosocial traits in individuals with HI…
-
CLINICAL_TRIALS trial_result · 2017-01-02Clinical Trial Update: HIV Prevention for PLHIV: Evaluation of an Intervention Toolkit for HIV Care & Treatment Settings [NA]
A CDC-sponsored study evaluating an intervention toolkit intended to support HIV prevention within HIV care and treatment settings has compl…
-
CLINICAL_TRIALS research · 2016-12-29Clinical Trial Update: A Roll-over Observational Study for the Extended Follow-up of the Volunteers of the ISS T-003 Trial
This document reports a roll-over observational study designed for extended follow-up of volunteers from the ISS T-003 trial, focusing on HI…
-
CLINICAL_TRIALS trial_result · 2016-12-26Clinical Trial Update: A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117 [Phase 1]
Phase 1, open-label, dose-escalation study evaluating the safety, pharmacokinetics, and antiretroviral activity of the HIV antibody 3BNC117 …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-23Clinical Trial Update: Treatment of Acute HIV Infection With Quad Fixed-dose Combination (FDC) Tablet [Phase 3]
This clinical trial update reports the completion and posting of Phase 3 results for a quad fixed-dose combination tablet evaluating treatme…
-
CLINICAL_TRIALS trial_result · 2016-12-23Clinical Trial Update: Addition of Raltegravir to Established Antiretroviral Suppressive Therapy [Phase 4]
A Phase 4 trial assessing the addition of raltegravir to established antiretroviral suppressive therapy in people with HIV was terminated, w…
-
FDA approval · 2016-12-22FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for NORVIR (ritonavir) submitted by AbbVie Inc.
-
CLINICAL_TRIALS trial_result · 2016-12-21Clinical Trial Update: HIV With Innovative Group Antenatal Care in Two African Countries [NA]
A completed clinical trial evaluating innovative group antenatal care for pregnant people living with HIV in two African countries.
-
FDA approval · 2016-12-20FDA Approved: TIVICAY — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for Tivicay (dolutegravir sodium) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2016-12-20Clinical Trial Update: Spurring Innovation to Promote HIV Testing: An RCT Evaluating Crowdsourcing [NA]
This randomized trial, sponsored by the University of North Carolina, evaluated crowdsourcing as a strategy to promote HIV testing; the stud…
-
CLINICAL_TRIALS research · 2016-12-20Clinical Trial Update: Prevalence of Liver Fibrosis and Progression of Liver Fibrosis
This update reports on a clinical trial examining the prevalence of liver fibrosis and its progression in people with HIV infection and chro…
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status [Phase 1]
Phase 1 study evaluating how HIV infection status influences the cellular pharmacology of antiretrovirals tenofovir disoproxil fumarate and …
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Handheld Computers to Improve Adherence to Anti-HIV Drug Regimens [Phase 2]
A Phase 2 trial evaluated whether handheld computers could improve adherence to HIV drug regimens. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Vitamin A to Reduce HIV in Vaginal Secretions and Prevent Viral Transmission [Phase 2]
A Phase 2 trial examined whether Vitamin A supplementation can reduce HIV presence in vaginal secretions and prevent transmission; the study…
-
FDA approval · 2016-12-14FDA Tentative Approval: LAMIVUDINE — Supplemental Application (Strides Pharma Science Limited)
FDA issued tentative approval for Strides Pharma Science Limited's generic lamivudine under an ANDA, signaling potential US market approval …
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV [Phase 2]
This report notes the completion of a Phase 2 clinical trial evaluating a therapeutic HIV vaccine in combination with interleukin-2 to boost…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection [NA]
A controlled clinical trial evaluating cytotoxic T lymphocyte (CTL) infusion after combination antiretroviral therapy for asymptomatic HIV-1…
-
CLINICAL_TRIALS withdrawal · 2016-12-14Clinical Trial Update: A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113) [NA]
This clinical trial evaluating L-735,524, an HIV protease inhibitor, in combination with interleukin-2 in HIV-infected individuals has been …
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients [Phase 1, Phase 2]
A Phase 1/2 trial evaluating Interleukin-12 for treating cryptosporidiosis in AIDS patients has been terminated.
-
CLINICAL_TRIALS withdrawal · 2016-12-14Clinical Trial Update: Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating daily tenofovir disoproxil fumarate to prevent HIV infection among sex workers in Cambodia has been withd…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3 [NA]
A pilot trial evaluating immunization with HIV-1 antigen-pulsed allogeneic dendritic cells in asymptomatic HIV-infected patients with CD4 co…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Treatment of Chronic Cryptosporidiosis in AIDS Patients [NA]
This clinical trial update reports that a study on treating chronic cryptosporidiosis in AIDS patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests [NA]
A pilot study evaluated the use of simultaneous rapid tests for HIV, hepatitis B, and hepatitis C; the trial is completed and results were p…
-
FDA approval · 2016-12-07FDA Tentative Approval: TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Strides Pharma Science Limited)
FDA granted tentative approval for Strides Pharma Science Limited's generic Tenofovir Disoproxil Fumarate. The product is considered bioequi…